While the Apple Watch series has had functionality for some time now, Fitbit may soon introduce the ability to detect irregular heart rhythms in its line of wearable products.
The company launched the Fitbit heart study which aims to find out if its heart rate detection products are capable of detecting atrial fibrillation (AFib), which is a specific type of irregular heartbeat. You can find out more about AFib and sign up for the trial here.
The trial is open to any resident of the United States, 22 years of age or older, who owns one of the following Fitbit products:
If you choose to participate, Fitbit will notify you if it detects an irregular heartbeat that could indicate AFib and, after sending the notification, “will put you in touch with a doctor for a free consultation to discuss the next steps”.
The company also guarantees that the data is confidential and strictly for the purposes of this study.
Google sues Apple
As previously mentioned, the Apple Watch has had this functionality for some time, with a similar study (Apple Heart Study) carried out in November 2017, which led to the deployment of the functionality on all past and present Apple watches.
With Google’s parent company Alphabet officially declaring that he will buy Fitbit in November 2019, it is not surprising that the study was pushed to this stage.
If the feature is rolled out to all compatible Fitbit devices, it will give the brand a better chance of competing with the Apple Watch series. The same can be said of the rumor Google Pixel Watch – it would be very logical for this future competitor in the field of smart watches to make full use of the acquisition of its parent company.